New funding: Seattle biotech company Mozart Therapeutics announced $25 million in new funding Wednesday to further its development of therapies for celiac and other autoimmune conditions. The therapy: The fresh cash… Read More
— Loni Mahanta, formerly vice president of government relations & public policy for Zillow Group, joined NFT marketplace OpenSea in a similar role. OpenSea uses blockchain technology to sell NFTs,… Read More
When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
A year and a few months since its founding, Mozart Therapeutics has secured $55 million to develop therapies for celiac disease and other immune-related conditions, the company announced Tuesday. The… Read More